CAM HSBIOTECH-U(09069.HK)

Last Updated 08:00:00
longbridge loading
Company Encyclopedia
View More
name
CAM HSBIOTECH-U
09069.HK
News
View More

WuXi AppTec Highlights Global CRDMO Growth and Innovation Platform in Latest Presentation

WuXi AppTec Co. Ltd. has presented its business strategy and performance in the CRDMO sector, highlighting a robust pipeline with 2,889 preclinical and Phase I molecules, 374 in Phase II, and 87 in Phase III as of Q3 2025. The company reported an adjusted non-IFRS net profit of RMB 15.0 billion in 2025, with a net profit margin of 32.9%. WuXi AppTec is expanding its global presence in regions including Boston, New Jersey, and Munich.

Reuters·
SH
603259
+0.71%
HK
02359
+0.92%
Reuters·
SH
603259
+0.71%
HK
02359
+0.92%

Akeso Reports Cadonilimab Outperforms PD-1 Inhibitors in First-Line PD-L1-Low Gastric Cancer Study

Akeso Inc. reported that cadonilimab plus chemotherapy outperformed PD-1 inhibitors in a study for first-line treatment of advanced gastric cancer with PD-L1 CPS

Reuters·
HK
09926
-0.74%
Reuters·
HK
09926
-0.74%

Hong Kong Stocks Rise for 4th Session

Hong Kong stocks rose 71 points (0.3%) to 26,917, marking the fourth consecutive session of gains, driven by consumer stocks and supported by AI advancements in China. The IPO market is expected to remain strong in 2026. However, sentiment was affected by a dip in U.S. futures and caution ahead of China's December trade figures. Notable early movers included Nongfu Spring (+6.4%), Kuaishou Tech (+4.3%), Hansoh Pharma (+3.2%), and Chow Tai Fook (+1.9%).

Trading Economics·
HK
03692
-0.28%
HK
01929
-1.56%
Trading Economics·
HK
03692
-0.28%
HK
01929
-1.56%

The Hang Seng Index rose 268 points in half a day, with the 27,000 mark "gained and lost," as innovative drug stocks collectively surged. Three new stocks had a weak finish｜Hong Kong Stock Market Afternoon Session

The Hang Seng Index opened 350 points higher this morning, reaching a maximum of 27,143 points during the day, and closed at 26,877 points, up 268 points or 1.01%. Alibaba rose 3.5%, JD.com rose 1.11%, and Tencent rose 0.48%; Xiaomi, Meituan, and Baidu, on the other hand, declined. Innovative drug stocks collectively rose, with WuXi AppTec up 7.67% and CSPC PHARMA up 5.5%. Automotive stocks generally rose due to the consensus reached on electric vehicles between China and Europe, with BYD up 3.19%. The newly listed stocks today showed volatility, with Zhaoyi Innovation once rising over 53.5%

Stheadline·
US
BABA
-3.24%
HK
09988
+0.97%
SH
603259
+0.71%
Stheadline·
US
BABA
-3.24%
HK
09988
+0.97%
SH
603259
+0.71%

Wuxi Biologics Unveils Scaled Global CRDMO Platform Advancing Biologics Development

Wuxi Biologics (Cayman) Inc. has launched a global CRDMO platform to enhance biologics development. The platform offers comprehensive services across the biologics lifecycle, including monoclonal antibodies and viral vaccines. Key achievements include over 600 IND submissions, 25 commercial programs, and 74 Phase III projects, with high reliability metrics: 98.3% DS success rate and 100% success rate in regulatory inspections. The flexible service model allows global clients to access tailored contract services in research, development, and manufacturing.

Reuters·
US
WXXWY
+1.60%
HK
02269
-0.60%
Reuters·
US
WXXWY
+1.60%
HK
02269
-0.60%
© 2026 Longbridge｜Disclaimer